Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAYB4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,468
Award facts
- Contract value 100% obligated
- $18,467.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,467.86 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on a firm fixed-price basis. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428. Mounjaro is a diabetes medication used in military and federal healthcare systems, and this delivery order falls under the company's broader federal contract portfolio serving defense medical supply needs.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a wide range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The contract reflects AmerisourceBergen Drug Corp's established capability to meet federal medical procurement requirements and its critical role as a prime pharmaceutical vendor for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FAYB4?
SPE2DB25FAYB4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FAYB4 worth?
The government has obligated $18,468 on SPE2DB25FAYB4.
Is contract SPE2DB25FAYB4 an order under another contract?
Yes. SPE2DB25FAYB4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAYB4 competed?
The extent of competition for SPE2DB25FAYB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award